The Association Between Prepandemic ICU Performance and Mortality Variation in COVID-19 A Multicenter Cohort Study of 35,619 Critically Ill Patients

被引:2
|
作者
Bastos, Leonardo S. L. [1 ]
Hamacher, Silvio [1 ]
Kurtz, Pedro [2 ]
Ranzani, Otavio T. [4 ,5 ]
Zampieri, Fernando G. [2 ,6 ]
Soares, Marcio [2 ]
Bozza, Fernando A. [2 ,3 ]
Salluh, Jorge I. F. [2 ,3 ]
机构
[1] Pontif Catholic Univ Rio De Janeiro, Dept Ind Engn, Rio De Janeiro, RS, Brazil
[2] Hosp Copa Star, Dor Inst Res & Educ, Paulo Niemeyer State Brain Inst, Rio De Janeiro, Brazil
[3] Univ Fed Rio de Janeiro, Oswaldo Cruz Fdn, Natl Inst Infect Dis Evandro Chagas, Postgrad Program Internal Med, Rio De Janeiro, Brazil
[4] Univ Sao Paulo, Hosp Clin HCFMUSP, Heart Inst, Fac Med,Pulm Div, Sao Paulo, Brazil
[5] Univ Pompeu Fabra, BarcelonaInstitute Global Hlth, ISGlobal, CIBER Epidemiol & Salud Publ, Barcelona, Spain
[6] Univ Alberta, Fac Med & Dent, Dept Crit Care Med, Edmonton, AB, Canada
基金
比尔及梅琳达.盖茨基金会;
关键词
COVID-19; ICU ef fi ciency; ICU organization; mortality; pandemic; INTENSIVE-CARE UNITS; RESOURCE USE; OUTCOMES; VOLUME;
D O I
10.1016/j.chest.2023.10.011
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
BACKGROUND: During the COVID-19 pandemic, ICUs remained under stress and observed elevated mortality rates and high variations of outcomes. A knowledge gap exists regarding whether an ICU performing best during nonpandemic times would still perform better when under high pressure compared with the least performing ICUs. RESEARCH QUESTION: Does prepandemic ICU performance explain the risk-adjusted mortality variability for critically ill patients with COVID-19? STUDY DESIGN AND METHODS: This study examined a cohort of adults with real-time polymerase chain reaction-confirmed COVID-19 admitted to 156 ICUs in 35 hospitals from February 16, 2020, through December 31, 2021, in Brazil. We evaluated crude and adjusted in-hospital mortality variability of patients with COVID-19 in the ICU during the pandemic. Association of baseline (prepandemic) ICU performance and in-hospital mortality was examined using a variable life-adjusted display (VLAD) during the pandemic and a multivariable mixed regression model adjusted by clinical characteristics, interaction of performance with the year of admission, and mechanical ventilation at admission. RESULTS: Thirty-five thousand six hundred nineteen patients with confirmed COVID-19 were evaluated. The median age was 52 years, median Simplified Acute Physiology Score 3 was 42, and 18% underwent invasive mechanical ventilation. In-hospital mortality was 13% and 54% for those receiving invasive mechanical ventilation. Adjusted in-hospital mortality ranged from 3.6% to 63.2%. VLAD in the most efficient ICUs was higher than the overall median in 18% of weeks, whereas VLAD was 62% and 84% in the underachieving and least efficient groups, respectively. The least efficient baseline ICU performance group was associated independently with increased mortality (OR, 2.30; 95% CI, 1.45-3.62) after adjusting for patient characteristics, disease severity, and pandemic surge. INTERPRETATION: ICUs caring for patients with COVID-19 presented substantial variation in reduced mortality and less variability. Our findings suggest that achieving ICU efficiency by targeting improvement in organizational aspects of ICUs may impact outcomes, and therefore should be a part of the preparedness for future pandemics.
引用
收藏
页码:870 / 880
页数:11
相关论文
共 50 条
  • [31] In-hospital cardiac arrest in critically ill patients with covid-19: multicenter cohort study
    Hayek, Salim S.
    Brenner, Samantha K.
    Azam, Tariq U.
    Shadid, Husam R.
    Anderson, Elizabeth
    Berlin, Hanna
    Pan, Michael
    Meloche, Chelsea
    Feroz, Rafey
    O'Hayer, Patrick
    Kaakati, Rayan
    Bitar, Abbas
    Padalia, Kishan
    Perry, Daniel
    Blakely, Pennelope
    Gupta, Shruti
    Shaefi, Shahzad
    Srivastava, Anand
    Charytan, David M.
    Bansal, Anip
    Mallappallil, Mary
    Melamed, Michal L.
    Shehata, Alexandre M.
    Sunderram, Jag
    Mathews, Kusum S.
    Sutherland, Anne K.
    Nallamothu, Brahmajee K.
    Leaf, David E.
    BMJ-BRITISH MEDICAL JOURNAL, 2020, 371 : m3513
  • [32] The use of Tocilizumab in COVID-19 critically ill patients with renal impairment: a multicenter, cohort study
    Aljuhani, Ohoud
    Al Sulaiman, Khalid
    Korayem, Ghazwa
    Alharbi, Aisha
    Altebainawi, Ali F.
    Aldkheel, Shatha A.
    Alotaibi, Sarah G.
    Vishwakarma, Ramesh
    Alshareef, Hanan
    Alsohimi, Samiah
    AlFaifi, Mashael
    Al Shaya, Abdulrahman
    Alhaidal, Haifa A.
    Alsubaie, Raghad M.
    Alrashidi, Hessah
    Albarqi, Khalid J.
    Alangari, Dalal T.
    Alanazi, Reem M.
    Altaher, Noora M.
    Al-Dorzi, Hasan M.
    RENAL FAILURE, 2023, 45 (02)
  • [33] Risk factors for mortality in critically ill patients with COVID-19: a multicenter retrospective case-control study
    Jinghua Gao
    Li Zhong
    Ming Wu
    Jingjing Ji
    Zheying Liu
    Conglin Wang
    Qifeng Xie
    Zhifeng Liu
    BMC Infectious Diseases, 21
  • [34] Risk factors for mortality in critically ill patients with COVID-19: a multicenter retrospective case-control study
    Gao, Jinghua
    Zhong, Li
    Wu, Ming
    Ji, Jingjing
    Liu, Zheying
    Wang, Conglin
    Xie, Qifeng
    Liu, Zhifeng
    BMC INFECTIOUS DISEASES, 2021, 21 (01)
  • [35] The clinical outcomes of COVID-19 critically ill patients co-infected with other respiratory viruses: a multicenter, cohort study
    Al Sulaiman, Khalid
    Aljuhani, Ohoud
    Badreldin, Hisham A.
    Korayem, Ghazwa B.
    Alenazi, Abeer A.
    Alharbi, Ahlam H.
    Alghamdi, Albandari
    Alhubaishi, Alaa
    Altebainawi, Ali F.
    Bosaeed, Mohammad
    Alotaibi, Rand
    Alawad, Ahad
    Alnajjar, Nirvana
    Bin Saleh, Khalid
    Sait, Walaa A.
    Alsohimi, Samiah
    Alanizy, Meshari M.
    Almuqbil, Sarah A.
    Al Sulaihim, Ibrahim
    Vishwakarma, Ramesh
    Alalawi, Mai
    Alhassan, Fatimah
    Alghnam, Suliman
    BMC INFECTIOUS DISEASES, 2023, 23 (01)
  • [36] Microbial dynamics, risk factors and outcomes of secondary pneumonia in critically ill patients with COVID-19: A multicenter retrospective cohort study
    Hu, Geng-Ning
    Liu, Wei-Lun
    Chang, Chia-Hao
    Ruan, Sheng-Yuan
    Chung, Kuei-Pin
    Chien, Jung-Yien
    Yu, Chong-Jen
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2024, 123 (11) : 1186 - 1193
  • [37] Factors associated with mortality in critically ill patients with COVID-19
    de Almeida, Rafaela dos Santos Charao
    Klafke, Andre
    Garbini, Andresa Fontoura
    Carazai, Daniela dos Reis
    dos Santos, Fernanda Costa
    Lutkmeier, Raquel
    Baldon, Veridiana
    REVISTA DE EPIDEMIOLOGIA E CONTROLE DE INFECCAO, 2022, 12 (04):
  • [38] Predictors of mortality in critically ill patients with COVID-19 and diabetes
    Lazaro, A. P. P.
    Zaranza, M. S.
    Meneses, G. C.
    Aragao, N. L.
    Freire, M. V. P.
    Guimaraes, A. R.
    Beliero, A. M.
    Dantas, M. M. P.
    Forte, L. C.
    Martins, A. M. C.
    Daher, E. F.
    Albuquerque, P. L. M. M.
    da Silva Junior, G. B.
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2023, 56
  • [39] Sedation and analgesia in critically ill patients with COVID-19: a cohort retrospective study
    Aurilio, Caterina
    Corcione, Antonio
    Fraganza, Fiorentino
    Sansone, Pasquale
    Paladini, Antonella
    Passavanti, Maria Beatrice
    Pota, Vincenzo
    Coppolino, Francesco
    Molino, Francesca
    Pace, Maria Caterina
    SIGNA VITAE, 2021, 17 (05) : 52 - 57
  • [40] Pulmonary hypertension at admission predicts ICU mortality in elderly critically ill with severe COVID-19 pneumonia: retrospective cohort study
    Kurnik, Marko
    Bozic, Helena
    Vindisar, Anze
    Kolar, Petra
    Podbregar, Matej
    CARDIOVASCULAR ULTRASOUND, 2023, 21 (01)